First Pavlov Saint Petersburg University
Saint Petersburg, 197342, Russia
NCT Number: NCT04000178
From June 2018 to October 2018, patients from two distinct clinical centers were prospectively enrolled in the study and stratified (non-randomly) into either control group A, patients who received polyurethane stents (Rüsch, Teleflex), or experimental group B, patients who received silicone stents (Cook Medical). Each participant completed a survey one hour after stent insertion, in the middle of the stent dwelling period, and before stent removal or ureteroscopy noting body pain and overactive bladder via the visual analog scale pain (VASP) and overactive bladder (OAB) awareness tool, respectively. Additionally, the successfulness of stent placement, hematuria, number of unplanned visits, and stent encrustation rates were assessed within each group.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Saint Petersburg, 197342, Russia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients were prospectively enrolled in the study and stratified (non-randomly) into either group A - polyurethane - control group or group B - silicone - experimental group
silicone stent
Time frame: 4 weeks
At each follow-up appointment, patients completed a survey in which the visual analog scale pain (VASP) was filled
Time frame: 4 weeks
At each follow-up appointment, patients completed a survey in which the "bladder awareness tool" (VASP) was filled
St. Petersburg State Pavlov Medical University
Other
COMPARISON OF SILICONE VERSUS POLYURETHANE URETERAL STENTS: A PROSPECTIVE CONTROLLED STUDY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01310582
Calculi, Excessive Repair
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05455307
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New Taipei City, Taiwan
View Trial Details